Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Advanced Biomedical Technologies Inc.Financial_Report.xls
EX-10.1 - LOAN AGREEMENT - Advanced Biomedical Technologies Inc.abmt_ex101.htm
EX-99.2 - DISCLOSURE COMMITTEE CHARTER - Advanced Biomedical Technologies Inc.abmt_ex992.htm
EX-99.1 - AUDIT COMMITTEE CHARTER - Advanced Biomedical Technologies Inc.abmt_ex991.htm
EX-31.2 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex312.htm
EX-31.1 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex311.htm
EX-32.2 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex322.htm
10-K - ANNUAL REPORT - Advanced Biomedical Technologies Inc.abmt_10k.htm
EX-14.1 - CODE OF ETHICS - Advanced Biomedical Technologies Inc.abmt_ex141.htm
Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
     In connection with the Annual Report of Advanced Biomedical Technologies, Inc. (the "Company") on Form 10-K for the year ended October 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "report"), I, Hui Wang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)           The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
 
(2)
The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Dated this 29th day of January, 2015.
 
 
/s/ Hui WANG
Hui WANG
Director and Chief Executive Officer